83 FR 44282 - National Center for Advancing Translational Sciences; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 169 (August 30, 2018)

Page Range		44282-44282
FR Document		2018-18773

Federal Register, Volume 83 Issue 169 (Thursday, August 30, 2018)

[Federal Register Volume 83, Number 169 (Thursday, August 30, 2018)]
[Notices]
[Page 44282]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18773]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel CTSA.
    Date: September 13-14, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Brookside Conference Rooms A & B, 5701 Marinelli Road, Rockville, MD 
20852.
    Contact Person: Victor Henriquez, Ph.D., Scientific Review 
Officer, Office of Scientific Director, National Center for 
Advancing Translational Sciences (NCATS), National Institutes of 
Health, 6701 Democracy Blvd., Democracy 1, Room 1080, Bethesda, MD 
20892-4878, 301-435-0813, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 23, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-18773 Filed 8-29-18; 8:45 am]
 BILLING CODE 4140-01-P

44282 Federal Register / Vol. 83, No. 169 / Thursday, August 30, 2018 / Notices

patients face a debilitating and often individuals associated with the contract DEPARTMENT OF HEALTH AND
time fatal course of the disease. proposals, the disclosure of which HUMAN SERVICES
• Anti-complement drugs (including would constitute a clearly unwarranted
eculizumab) has the potential to treat invasion of personal privacy. National Institutes of Health
CHAPLE disease.
Name of Committee: Center for Scientific
National Center for Advancing
Development Stage Review Special Emphasis Panel; Shared and
Translational Sciences; Notice of
• Pre-clinical. High-end Mass Spectrometers.
Closed Meeting
• Clinical. Date: September 20–21, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Inventors Pursuant to section 10(d) of the
Agenda: To review and evaluate grant
applications.
Federal Advisory Committee Act, as
Dr. Michael J. Lenardo (NIAID), Dr.
Place: Hotel Nikko San Francisco, 222 amended, notice is hereby given of the
Helen Su (NIAID), Ahmet Ozen (NIAID),
William A. Comrie (NIAID), Mr. Rico C. Mason Street, San Francisco, CA 94102. following meeting.
Ardy (CeMM, Austria), and Dr. Kaan Contact Person: Sudha Veeraraghavan, The meeting will be closed to the
Boztug (CeMM, Austria). Ph.D., Scientific Review Officer, Center for public in accordance with the
Scientific Review, National Institutes of provisions set forth in sections
Intellectual Property Health, 6701 Rockledge Drive, Bethesda, MD 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
HHS Reference No. E–251–2016/0, 20892, 301–435–1504, as amended. The grant applications and
U.S. Provisional Patent Application sudha.veeraraghavan@nih.gov. the discussions could disclose
Number 62/394,630, filed September 14, Name of Committee: Surgical Sciences, confidential trade secrets or commercial
2016, and PCT/US2017/051413 filed Biomedical Imaging and Bioengineering property such as patentable material,
September 13, 2017. Integrated Review Group; Surgery, and personal information concerning
Anesthesiology and Trauma Study Section. individuals associated with the grant
Licensing Contact
Date: September 26–27, 2018
Yogikala Prabhu, Ph.D., 301–761– applications, the disclosure of which
Time: 8:00 a.m. to 5:00 p.m.
7789; prabhuyo@niaid.nih.gov. would constitute a clearly unwarranted
Agenda: To review and evaluate grant
applications
invasion of personal privacy.
Collaborative Research Opportunity
Place: Residence Inn Bethesda, 7335 Name of Committee: National Center for
The National Institute of Allergy and Wisconsin Avenue, Bethesda, MD 20814. Advancing Translational Sciences Special
Infectious Diseases is seeking statements Contact Person: Weihua Luo, MD, Ph.D., Emphasis Panel CTSA.
of capability or interest from parties Scientific Review Officer, Center for Date: September 13–14, 2018.
interested in collaborative research to Scientific Review, National Institutes of Time: 8:00 a.m. to 5:00 p.m.
further develop, evaluate or Health, 6701 Rockledge Drive, Room 5114, Agenda: To review and evaluate grant
commercialize the use of Eculizumab or MSC 7854, Bethesda, MD 20892, (301) 435– applications.
other complement inhibitory drugs for 1170, luow@csr.nih.gov. Place: Bethesda North Marriott Hotel &
the treatment of CHAPLE. For Name of Committee: Center for Scientific Conference Center, Brookside Conference
collaboration opportunities, please Review Special Emphasis Panel; PAR Panel: Rooms A & B, 5701 Marinelli Road,
contact Yogikala Prabhu, Ph.D., 301– Neural regulation of Cancer. Rockville, MD 20852.
761–7789; prabhuyo@niaid.nih.gov. Date: September 26, 2018. Contact Person: Victor Henriquez, Ph.D.,
Dated: August 18, 2018. Time: 12:00 p.m. to 4:00 p.m. Scientific Review Officer, Office of Scientific
Suzanne M. Frisbie, Agenda: To review and evaluate grant Director, National Center for Advancing
applications. Translational Sciences (NCATS), National
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute Place: National Institutes of Health, 6701 Institutes of Health, 6701 Democracy Blvd.,
of Allergy and Infectious Diseases. Rockledge Drive, Bethesda, MD 20892 Democracy 1, Room 1080, Bethesda, MD
(Virtual Meeting). 20892–4878, 301–435–0813, henriquv@
[FR Doc. 2018–18779 Filed 8–29–18; 8:45 am]
Contact Person: Rolf Jakobi, Ph.D., mail.nih.gov.
BILLING CODE 4140–01–P
Scientific Review Officer, Center for (Catalogue of Federal Domestic Assistance
Scientific Review, National Institutes of Program Nos. 93.859, Pharmacology,
DEPARTMENT OF HEALTH AND Health, 6701 Rockledge Drive, Room 6187, Physiology, and Biological Chemistry
HUMAN SERVICES MSC 7806, Bethesda, MD 20892, 301–495– Research; 93.350, B—Cooperative
1718, jakobir@mail.nih.gov. Agreements; 93.859, Biomedical Research
National Institutes of Health (Catalogue of Federal Domestic Assistance and Research Training, National Institutes of
Program Nos. 93.306, Comparative Medicine; Health, HHS)
Center for Scientific Review; Notice of 93.333, Clinical Research, 93.306, 93.333, Dated: August 23, 2018.
Closed Meetings 93.337, 93.393–93.396, 93.837–93.844, David D. Clary,
Pursuant to section 10(d) of the 93.846–93.878, 93.892, 93.893, National
Program Analyst, Office of Federal Advisory
Federal Advisory Committee Act, as Institutes of Health, HHS)
Committee Policy.
amended, notice is hereby given of the Dated: August 23, 2018. [FR Doc. 2018–18773 Filed 8–29–18; 8:45 am]
following meetings. David D. Clary, BILLING CODE 4140–01–P
The meetings will be closed to the
public in accordance with the Program Analyst, Office of Federal Advisory
amozie on DSK3GDR082PROD with NOTICES1

Committee Policy.
provisions set forth in sections
[FR Doc. 2018–18772 Filed 8–29–18; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and BILLING CODE 4140–01–P
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning

VerDate Sep<11>2014 17:25 Aug 29, 2018 Jkt 244001 PO 00000 Frm 00026 Fmt 4703 Sfmt 9990 E:\FR\FM\30AUN1.SGM 30AUN1

Document Created: 2018-08-30 01:20:34
Document Modified: 2018-08-30 01:20:34

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 13-14, 2018.
FR Citation		83 FR 44282

83 FR 44282 - National Center for Advancing Translational Sciences; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 169 (August 30, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health